MAINZ BIOMED N.V. - MYNZ

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$348K
QoQ value delta ($000)
-$5K (-1.42%)
Implied price effect (QoQ)
-1.38%
Shares
Total shares
229,812
QoQ shares delta
-90 (-0.04%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (MYNZ)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 3 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
JANE STREET GROUP, LLC 132 84,574 0.0%
Virtu Financial LLC 64 41,068 0.0%
UBS Group AG 40 26,110 0.0%
Steward Partners Investment Advisory, LLC 31 20,000 0.0%
MORGAN STANLEY 17 11,187 0.0%
XTX Topco Ltd 17 11,391 0.0%
Journey Advisory Group, LLC 15 10,000 0.0%
PROFESSIONAL ADVISORY SERVICES INC 13 10,000 0.0%
Tower Research Capital LLC (TRC) 6 4,000 0.0%
Keystone Financial Group, Inc. 6 5,300 0.0%
OSAIC HOLDINGS, INC. 3 2,190 0.0%
SBI Securities Co., Ltd. 2 1,289 0.0%
LANARK FINANCIAL, INC. 1 790 0.0%
Provenance Wealth Advisors, LLC 1 1,171 0.0%
CITIGROUP INC 0 42 0.0%
HighMark Wealth Management LLC 0 200 0.0%
NFSG Corp 0 500 0.0%